This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Pierre Fabre Medicament. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Andrew Phimister: Pharmaceutical Solid-State Inventions
Introduction
Andrew Phimister is an inventor associated with Kensington, California, and Pierre Fabre Medicament. His patent work concerns solid-state forms of a pharmaceutical compound and its salts, which may support the preparation of pharmaceutical compositions and dosage forms.
Latest Patents
The supplied information identifies one patent associated with Phimister: “Solid state forms of (S)-N-(3-(2-(((R)-1-hydroxypropan-2-yl)amino)-6-morpholinopyridin-4-yl)-4-methylphenyl)-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and salts thereof.” The disclosure describes solid-state forms of the compound and its salts, with potential use in pharmaceutical compositions and dosage forms for treating disease. The record lists 1 patent.
Career Highlights
Phimister’s listed patent reflects work on pharmaceutical solid-state forms, an area relevant to developing and preparing drug products. The supplied information associates him with Pierre Fabre Medicament.
Collaborations
The patent information names Stephen W. Kaldor and Toufike Kanouni as Phimister’s coworkers.
Conclusion
Andrew Phimister’s listed invention focuses on solid-state forms of a pharmaceutical compound and its salts, connecting his patent work with pharmaceutical formulation and drug-product preparation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile